Canadian Journal of Infectious Diseases (Jan 1994)

Dexamethasone Therapy for Bacterial Meningitis: Better Never Than Late?

  • Susan M King,
  • Barbara Law,
  • Joanne M Langley,
  • Helen Heurter,
  • Diane Bremner,
  • Elaine E Wang,
  • Ronald Gold

DOI
https://doi.org/10.1155/1994/257198
Journal volume & issue
Vol. 5, no. 5
pp. 210 – 215

Abstract

Read online

A multicentre randomized controlled trial was conducted in children with bacterial meningitis using dexamethasone or placebo for four days within 24 h of starting antibiotics. Primary outcomes were hearing loss and neurological abnormalities at 12 months after meningitis. The dexamethasone (n=50) and placebo (n=51) groups were similar in age, severity of illness and etiological agent. Hearing loss occurred in 10% and 11% of the dexamethasone and placebo groups and neurological deficits occurred in 20% and 18% of patients, respectively. Duodenal perforation occurred in one dexamethasone-treated child. In conclusion, there was no significant benefit in those receiving dexamethasone. The lack of benefit may have been due to the delay in administration of dexamethasone (median delay of 11 h after antibiotics). Therefore, if dexamethasone is used for meningitis it should be given immediately with the antibiotic.